An emerging phenotype of central nervous system involvement in Pompe disease: from bench to bedside and beyond.

dc.contributor.author

Korlimarla, Aditi

dc.contributor.author

Lim, Jeong-A

dc.contributor.author

Kishnani, Priya S

dc.contributor.author

Sun, Baodong

dc.date.accessioned

2020-08-11T16:54:56Z

dc.date.available

2020-08-11T16:54:56Z

dc.date.issued

2019-07

dc.date.updated

2020-08-11T16:54:55Z

dc.description.abstract

Pompe disease (PD) is a lysosomal storage disorder caused by deficiency of the lysosomal enzyme acid-alpha glucosidase (GAA). Pathogenic variants in the GAA gene lead to excessive accumulation of lysosomal glycogen primarily in the cardiac, skeletal, and smooth muscles. There is growing evidence of central nervous system (CNS) involvement in PD. Current research is focused on determining the true extent of CNS involvement, its effects on behavior and cognition, and effective therapies that would correct the disease in both muscle and the CNS. This review article summarizes the CNS findings in patients, highlights the importance of research on animal models, explores the probable success of gene therapy in reversing CNS pathologies as reported by some breakthrough preclinical studies, and emphasizes the need to follow patients and monitor for CNS involvement over time. Lessons learned from animal models (bench) and from the literature available to date on patients will guide future clinical trials in patients (bedside) with PD. Our preliminary studies in infantile PD show that some patients are susceptible to early and extensive CNS pathologies, as assessed by neuroimaging and developmental assessments. This article highlights the importance of neuroimaging which could serve as useful tools to diagnose and monitor certain CNS pathologies such as white matter hyperintense foci (WMF) in the brain. Longitudinal studies with large sample sizes are warranted at this time to better understand the emergence, progression and consequences of CNS involvement in patients with PD.

dc.identifier

atm-07-13-289

dc.identifier.issn

2305-5839

dc.identifier.issn

2305-5847

dc.identifier.uri

https://hdl.handle.net/10161/21303

dc.language

eng

dc.publisher

AME Publishing Company

dc.relation.ispartof

Annals of translational medicine

dc.relation.isversionof

10.21037/atm.2019.04.49

dc.subject

GAAKO mouse model

dc.subject

Pompe disease (PD)

dc.subject

central nervous system (CNS)

dc.subject

gene therapy

dc.subject

white matter hyperintense foci (WMF)

dc.title

An emerging phenotype of central nervous system involvement in Pompe disease: from bench to bedside and beyond.

dc.type

Journal article

duke.contributor.orcid

Korlimarla, Aditi|0000-0002-0680-9949

duke.contributor.orcid

Kishnani, Priya S|0000-0001-8251-909X

duke.contributor.orcid

Sun, Baodong|0000-0002-2191-0025

pubs.begin-page

289

pubs.issue

13

pubs.organisational-group

School of Medicine

pubs.organisational-group

Pediatrics, Medical Genetics

pubs.organisational-group

Duke

pubs.organisational-group

Pediatrics

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Staff

pubs.publication-status

Published

pubs.volume

7

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Emerging phenotypes of CNS in PD.pdf
Size:
298.42 KB
Format:
Adobe Portable Document Format